Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies -- Ignore unavailable to you. Want to Upgrade?

To: Panita who wrote (61567)	3/15/1999 9:57:00 AM
From: GBT	Read Replies (1) \| Respond to of 119973

POSS on CNBC Tuesday, Big news Possis Medical's AngioJet Wins FDA Approval for New Use Possis Medical's AngioJet Wins FDA Approval for New Use Washington, March 12 (Bloomberg) -- Possis Medical Inc. said its already-approved AngioJet device won wider government clearance for use inside the heart. The company said it won U.S. Food and Drug Administration approval of the artery-clearing device for use in patients who are undergoing a heart attack, who have severe chest pains known as angina, or who can't take drugs that are generally used to dissolve a blood clot. ''It's a very broad approval,'' said Russel Carlson, chief financial officer of Possis. ''It's everything that we asked for, and it allows us to start marketing now.'' News of the approval came after the close of trading on U.S. markets. Shares in the money losing device-maker closed unchanged at 12 3/8.